Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLoans and Notes ReceivablesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares OutstandingShares OutstandingShares Repurchased
Ratios

SBC Medical Group Holdings (SBC) EBIAT (2023 - 2025)

SBC Medical Group Holdings filings provide 3 years of EBIAT readings, the most recent being $14.2 million for Q4 2025.

  • On a quarterly basis, EBIAT rose 117.16% to $14.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $51.0 million, a 9.18% increase, with the full-year FY2025 number at $51.0 million, up 9.38% from a year prior.
  • EBIAT hit $14.2 million in Q4 2025 for SBC Medical Group Holdings, up from $12.8 million in the prior quarter.
  • In the past five years, EBIAT ranged from a high of $21.5 million in Q1 2025 to a low of $2.4 million in Q2 2025.
  • Median EBIAT over the past 3 years was $11.3 million (2023), compared with a mean of $11.4 million.
  • The widest YoY moves for EBIAT: up 353.01% in 2025, down 86.85% in 2025.
  • SBC Medical Group Holdings' EBIAT stood at $15.0 million in 2023, then plummeted by 56.52% to $6.5 million in 2024, then surged by 117.16% to $14.2 million in 2025.
  • The last three reported values for EBIAT were $14.2 million (Q4 2025), $12.8 million (Q3 2025), and $2.4 million (Q2 2025) per Business Quant data.